Continuous Glucose Monitoring Market Size 2025–2034

Continuous Glucose Monitoring Market - By Component, By End Use - Global Forecast, 2025 - 2034

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology and Scope

1.1&nbsp;&nbsp;&nbsp; Market scope and definition

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Data mining sources

1.3.1&nbsp;&nbsp;&nbsp; Global

1.3.2&nbsp;&nbsp;&nbsp; Regional/country

1.4&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.4.1&nbsp;&nbsp;&nbsp; Base year calculation

1.4.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.6&nbsp;&nbsp;&nbsp; Forecast model

1.7&nbsp;&nbsp;&nbsp; Research assumptions and limitations

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600&nbsp;synopsis

2.2&nbsp;&nbsp;&nbsp; Key market trends

2.2.1&nbsp;&nbsp;&nbsp; Regional trends

2.2.2&nbsp;&nbsp;&nbsp; Component trends

2.2.3&nbsp;&nbsp;&nbsp; End use trends

2.3&nbsp;&nbsp;&nbsp; CXO perspectives: Strategic imperatives

2.3.1&nbsp;&nbsp;&nbsp; Key decision points for industry executives

2.3.2&nbsp;&nbsp;&nbsp; Critical success factors for market players

2.4&nbsp;&nbsp;&nbsp; Future outlook and strategic recommendations

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.1.1&nbsp;&nbsp;&nbsp; Supplier landscape

3.1.2&nbsp;&nbsp;&nbsp; Value addition at each stage

3.1.3&nbsp;&nbsp;&nbsp; Factor affecting the value chain

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Increasing number of people suffering from diabetes, globally

3.2.1.2&nbsp;&nbsp;&nbsp; Rising demand for continuous monitoring devices

3.2.1.3&nbsp;&nbsp;&nbsp; Technological advancements in devices

3.2.1.4&nbsp;&nbsp;&nbsp; Increasing government initiatives to generate awareness regarding diabetes

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls and challenges

3.2.2.1&nbsp;&nbsp;&nbsp; High cost related to devices

3.2.2.2&nbsp;&nbsp;&nbsp; Stringent regulatory scenario

3.2.3&nbsp;&nbsp;&nbsp; Market opportunities

3.2.3.1&nbsp;&nbsp;&nbsp; Expansion in emerging markets

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.4.1&nbsp;&nbsp;&nbsp; North America

3.4.2&nbsp;&nbsp;&nbsp; Europe

3.4.3&nbsp;&nbsp;&nbsp; Asia Pacific

3.5&nbsp;&nbsp;&nbsp; Technological advancements

3.5.1&nbsp;&nbsp;&nbsp; Current technological trends

3.5.2&nbsp;&nbsp;&nbsp; Emerging technologies

3.6&nbsp;&nbsp;&nbsp; Supply chain and distribution analysis

3.7&nbsp;&nbsp;&nbsp; Pricing analysis, 2024

3.8&nbsp;&nbsp;&nbsp; Future market trends

3.9&nbsp;&nbsp;&nbsp; Gap analysis

3.10&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.11&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2024

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis

4.3&nbsp;&nbsp;&nbsp; Company matrix analysis

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Key developments

4.6.1&nbsp;&nbsp;&nbsp; Mergers and acquisitions

4.6.2&nbsp;&nbsp;&nbsp; Partnerships and collaborations

4.6.3&nbsp;&nbsp;&nbsp; New product launches

4.6.4&nbsp;&nbsp;&nbsp; Expansion plans

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Component, 2021 - 2034 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Transmitters

5.3&nbsp;&nbsp;&nbsp; Sensors

5.4&nbsp;&nbsp;&nbsp; Receivers

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Hospitals

6.3&nbsp;&nbsp;&nbsp; Home care settings

6.4&nbsp;&nbsp;&nbsp; Diagnostic centres and clinics

6.5&nbsp;&nbsp;&nbsp; Other end use

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; North America

7.2.1&nbsp;&nbsp;&nbsp; U.S.

7.2.2&nbsp;&nbsp;&nbsp; Canada

7.3&nbsp;&nbsp;&nbsp; Europe

7.3.1&nbsp;&nbsp;&nbsp; Germany

7.3.2&nbsp;&nbsp;&nbsp; France

7.3.3&nbsp;&nbsp;&nbsp; UK

7.3.4&nbsp;&nbsp;&nbsp; Italy

7.3.5&nbsp;&nbsp;&nbsp; Spain

7.3.6&nbsp;&nbsp;&nbsp; Netherlands

7.3.7&nbsp;&nbsp;&nbsp; Sweden

7.3.8&nbsp;&nbsp;&nbsp; Russia

7.3.9&nbsp;&nbsp;&nbsp; Denmark

7.3.10&nbsp;&nbsp;&nbsp; Finland

7.3.11&nbsp;&nbsp;&nbsp; Norway

7.3.12&nbsp;&nbsp;&nbsp; Poland

7.3.13&nbsp;&nbsp;&nbsp; Switzerland

7.3.14&nbsp;&nbsp;&nbsp; Belgium

7.3.15&nbsp;&nbsp;&nbsp; Lithuania

7.3.16&nbsp;&nbsp;&nbsp; Latvia

7.3.17&nbsp;&nbsp;&nbsp; Estonia

7.4&nbsp;&nbsp;&nbsp; Asia Pacific

7.4.1&nbsp;&nbsp;&nbsp; China

7.4.2&nbsp;&nbsp;&nbsp; Japan

7.4.3&nbsp;&nbsp;&nbsp; India

7.4.4&nbsp;&nbsp;&nbsp; Australia

7.4.5&nbsp;&nbsp;&nbsp; South Korea

7.4.6&nbsp;&nbsp;&nbsp; Taiwan

7.4.7&nbsp;&nbsp;&nbsp; Indonesia

7.4.8&nbsp;&nbsp;&nbsp; Vietnam

7.5&nbsp;&nbsp;&nbsp; Latin America

7.5.1&nbsp;&nbsp;&nbsp; Brazil

7.5.2&nbsp;&nbsp;&nbsp; Mexico

7.5.3&nbsp;&nbsp;&nbsp; Argentina

7.5.4&nbsp;&nbsp;&nbsp; Colombia

7.5.5&nbsp;&nbsp;&nbsp; Chile

7.5.6&nbsp;&nbsp;&nbsp; Peru

7.6&nbsp;&nbsp;&nbsp; Middle East and Africa

7.6.1&nbsp;&nbsp;&nbsp; South Africa

7.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

7.6.3&nbsp;&nbsp;&nbsp; UAE

7.6.4&nbsp;&nbsp;&nbsp; Turkey

7.6.5&nbsp;&nbsp;&nbsp; Egypt

7.6.6&nbsp;&nbsp;&nbsp; Israel

7.6.7&nbsp;&nbsp;&nbsp; Kuwait

7.6.8&nbsp;&nbsp;&nbsp; Qatar

Chapter 8&nbsp;&nbsp;&nbsp;Company Profiles

8.1&nbsp;&nbsp;&nbsp; Abbott Laboratories

8.2&nbsp;&nbsp;&nbsp; A. Menarini Diagnostics

8.3&nbsp;&nbsp;&nbsp; Dexcom

8.4&nbsp;&nbsp;&nbsp; i-SENS

8.5&nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche

8.6&nbsp;&nbsp;&nbsp; Med Trust

8.7&nbsp;&nbsp;&nbsp; Medtronic

8.8&nbsp;&nbsp;&nbsp; Medtrum Technologies

8.9&nbsp;&nbsp;&nbsp; Senseonics

8.10&nbsp;&nbsp;&nbsp; Sinocare

8.11&nbsp;&nbsp;&nbsp; Zhejiang POCTech

Continuous Glucose Monitoring Market

Get a free sample of this report